Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Petrini

Showing results (211-220 of 254) with videos related to

Pageof 26
Sort By:
Frontiers in Oncology|October 5, 2020
Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2Sara Galimberti, Mario Petrini, Claudia Baratè, et al.
British Journal of Haematology|December 8, 2011
Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio LinfomiFrancesco Merli, Stefano Luminari, Fiorella Ilariucci, et al.
Oncotarget|August 17, 2016
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patientsMonica Bocchia, Sara Galimberti, Lara Aprile, et al.
Cancers|July 8, 2020
Digital Droplet PCR is a Specific and Sensitive Tool for Detecting IDH2 Mutations in Acute Myeloid LeuKemia PatientsSusanna Grassi, Francesca Guerrini, Elena Ciabatti, et al.
British Journal of Haematology|December 19, 2013
Safety and efficacy of (90) yttrium-ibritumomab-tiuxetan for untreated follicular lymphoma patients. An Italian cooperative studyAdalberto Ibatici, Gian Matteo Pica, Sandro Nati, et al.
The New England Journal of Medicine|January 26, 2007
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropeniaOliver A Cornely, Johan Maertens, Drew J Winston, et al.
Blood|March 31, 2022
Activation of the zinc-sensing receptor GPR39 promotes T-cell reconstitution after hematopoietic cell transplant in miceLorenzo Iovino, Kirsten Cooper, Paul deRoos, et al.
Cytotherapy|November 3, 2009
Consistent bone marrow-derived cell mobilization following repeated short courses of granulocyte-colony-stimulating factor in patients with amyotrophic lateral sclerosis: results from a multicenter prospective trialCorrado Tarella, Sergio Rutella, Francesca Gualandi, et al.
Leukemia & Lymphoma|April 29, 2016
A systematic literature review and network meta-analysis of treatments for patients with untreated multiple myeloma not eligible for stem cell transplantationKatja Weisel, Chantal Doyen, Meletios Dimopoulos, et al.
Transplantation|June 27, 2008
Changes In CD8+57+ T lymphocyte expansions after autologous hematopoietic stem cell transplantation correlate with changes in torquetenovirus viremiaFabrizio Maggi, Maggi Fabrizio, Valentina Ricci, et al.
Pageof 26

Showing results (211-220 of 254) with videos related to

Sort By:
Pageof 26
Frontiers in Oncology|October 5, 2020
Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2Sara Galimberti, Mario Petrini, Claudia Baratè, et al.
British Journal of Haematology|December 8, 2011
Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio LinfomiFrancesco Merli, Stefano Luminari, Fiorella Ilariucci, et al.
Oncotarget|August 17, 2016
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patientsMonica Bocchia, Sara Galimberti, Lara Aprile, et al.
Cancers|July 8, 2020
Digital Droplet PCR is a Specific and Sensitive Tool for Detecting IDH2 Mutations in Acute Myeloid LeuKemia PatientsSusanna Grassi, Francesca Guerrini, Elena Ciabatti, et al.
British Journal of Haematology|December 19, 2013
Safety and efficacy of (90) yttrium-ibritumomab-tiuxetan for untreated follicular lymphoma patients. An Italian cooperative studyAdalberto Ibatici, Gian Matteo Pica, Sandro Nati, et al.
The New England Journal of Medicine|January 26, 2007
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropeniaOliver A Cornely, Johan Maertens, Drew J Winston, et al.
Blood|March 31, 2022
Activation of the zinc-sensing receptor GPR39 promotes T-cell reconstitution after hematopoietic cell transplant in miceLorenzo Iovino, Kirsten Cooper, Paul deRoos, et al.
Cytotherapy|November 3, 2009
Consistent bone marrow-derived cell mobilization following repeated short courses of granulocyte-colony-stimulating factor in patients with amyotrophic lateral sclerosis: results from a multicenter prospective trialCorrado Tarella, Sergio Rutella, Francesca Gualandi, et al.
Leukemia & Lymphoma|April 29, 2016
A systematic literature review and network meta-analysis of treatments for patients with untreated multiple myeloma not eligible for stem cell transplantationKatja Weisel, Chantal Doyen, Meletios Dimopoulos, et al.
Transplantation|June 27, 2008
Changes In CD8+57+ T lymphocyte expansions after autologous hematopoietic stem cell transplantation correlate with changes in torquetenovirus viremiaFabrizio Maggi, Maggi Fabrizio, Valentina Ricci, et al.
Pageof 26